Pharma-Bio 3Q18 Kickoffs near $7 billion in Europe/Russia/Turkey, an Industrial Info Market Brief

The Pharmaceutical-Biotech Industry has the potential to launch construction on almost $7 billion in capital and MRO projects in Europe, Russia and Turkey in third-quarter 2018. The projects include everything from routine scheduled maintenance to drug manufacturing plant expansions. While Western Europe is a much more mature market than the other regions, it nevertheless still accounts for approximately a third of the projects and nearly $4 billion of the 3Q18 total. The abundance of projects in the emerging regions give proof to the truth of the global expansion of the industry.